9
Views
6
CrossRef citations to date
0
Altmetric
Original Article

Angiographic abnormalities of experimental autoimmune uveoretinitis

, , , &
Pages 1149-1155 | Received 08 Aug 1995, Accepted 29 Jul 1996, Published online: 02 Jul 2009
 

Abstract

Purpose. Experimental autoimmune uveoretinitis (EAU) is an invaluable animal model for studying inflammatory eye disease in humans. Indocyanine green (ICG) is a fluorescent dye that can be used to image both retinal and choroidal vessels. This study was performed to examine the retinal and choroidal vascular abnormalities of a rat model of EAU using ICG and fluo-rescein as the contrast media and to assess the suitability of this model for studying ICG angiographic abnormalities in inflammatory eye disease in humans.

Methods. Twenty-six male black-hooded Lister rats were inoculated with bovine retinal S-antigen plus adjuvant with or without Bordetella pertussis antigen. Fluorescein and ICG angio-grams were performed at different stages of clinical disease with a scanning laser ophthalmoscope.

Results. EAU was a more severe and primarily choroidal disease in rats given Bordetella pertussis, but no animals showed evidence of dye leakage from large choroidal vessels. There was frank leakage of indocyanine green from retinal vessels. Leakage of both fluorescein and ICG from retinal vessels largely correlated with disease activity. Retinal pigment epithelial lesions either corresponded to areas of hypofluorescence on the ICG angiogram alone or were represented by areas of ICG hyperfluo-rescence that had overlying areas of fluorescein leakage from retinal capillaries.

Conclusions. This study has demonstrated the vascular abnormalities of this model of EAU using ICG and fluorescein as the contrast media. The suitability of this model for studying ICG angiographic abnormalities in inflammatory eye disease in humans is encouraging.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.